Navigation Links
Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
Date:5/9/2008

BASINGSTOKE, England and PHILADELPHIA, May 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that ordinary shareholders approved the scheme of arrangement proposed in a circular to shareholders dated 16 April 2008 (the "Circular"), without modification, at a meeting convened by the Court and held today.

At a hearing convened for 22 May 2008, the High Court is expected to approve the scheme of arrangement, which will result in the establishment of a new UK listed, Jersey incorporated holding company, Shire Limited, above Shire plc. As is the case for Shire plc, the new holding company will have its primary listing on the London Stock Exchange and its American Depositary Shares will be traded on NASDAQ.

At the extraordinary general meeting (the "EGM") which immediately followed the Court meeting, shareholders also approved, without modification, all resolutions proposed in the notice of the EGM included in the Circular. Among other things, the proposed resolutions sought shareholder approval for the scheme of arrangement, to amend Shire plc's articles and approval for the reduction of capital of Shire Limited for the creation of distributable reserves.

Shareholders at the EGM also approved resolutions proposing new employee share save and share option schemes by Shire Limited, the principal terms of which were summarised in the Circular.
The full results of the meetings were as follows:

POLL RESULT FOR THE COURT MEETING

Resolution to approve the scheme:

Number of votes for: 334,508,504 99.78%

Number of votes against: 728,935 0.22%

Number of voters for: 853 95.63%

Number of voters against: 39 4.37%

PROXY VOTES FOR THE EGM

All resolutions were put to the EGM and approved on a show of hands. The prox
'/>"/>

SOURCE Shire PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...lease is available in German . , The concep...dern physics. The most famous example is that of q...rons. Now Prof. Bella Lake from Helmholtz-Zentrum ...ntists report for the first time an experimental r...bserved in a condensed matter system. , The conc...
(Date:11/27/2009)..., PARIS, November 27 ...o market Oralair(R) in both adults and children,th... first country where,Oralair(R) has been marketed,...r(R) is now registered in Austria, Belgium, Bulgar...ermany, Greece, Hungary, Ireland, Italy,Latvia, L...
(Date:11/25/2009)... , DURHAM, N.C., Nov. 25 Rese...first energy-efficient, single-treatment water pur...n nanotubes to Andhra Pradesh, Minister of Rural W...ers in Hyderabad, India today. Initial tests, perf...ur, confirmed that the majority of the drinking wa...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov....been a painful year. Not so for BodyLogicMD. The ...pert physicians specializing exclusively in medica...the number of physicians in its network sinc...is in progress to add more physician-owned centers...
Breaking Biology Technology:Spinons -- confined like quarks 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
...ot chocolate present risk, OAKLAND, Calif., Jan. ...-- whether from coffee, tea, caffeinated soda or h...iage, according a new study,by the Kaiser Permanen...,the first time, pregnancy-related symptoms of nau... interfere with the determination of caffeine,s tr...
...t NNRTI to show antiviral activity in patients wit... BRIDGEWATER, N.J., Jan. 18 The U.S. Food and Dru...roval to the anti-HIV,medication INTELENCE (etravi...transcriptase inhibitor (NNRTI) to show antiviral ...with HIV resistant to a NNRTI and,other antiretrov...
...Eli Lilly and Company,strongly objects to implicat...y that the company has suppressed results of negat...ate article in The New England Journal of,Medicine...amples of how the,industry purportedly suppresses ...es, story inaccurate when it comes to Prozac -- th...
Other Biology Technology:Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 2Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 3Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk 4FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 2FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 3FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 4FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 5FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 6FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 7FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy 8In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4
(Date:11/26/2009)...d sharks are some of the Ocean,s most distinctive ...have this strange head shape, says Michelle McCom...eason is the shark,s vision. ,Perhaps their visual..., says McComb, giving the sharks excellent stereo... McComb, there were two schools of thought on this...
(Date:11/26/2009)..., Mass. (November 26, 2009) Whitehead researchers...uman cells to pinpoint specific genes and proteins...cience . , In most human cell cultures genes are...her and one from the mother. Gene inactivation by ... copy is inactivated, the second copy usually rema...
(Date:11/25/2009)...a hormone produced in the stomach, may be used to ...arkinson,s disease, Yale School of Medicine resear...e of the Journal of Neuroscience . , Parkinson,...neurons in an area of the midbrain known as the su...production. Reduced production of dopamine in lat...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage 12936 1Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage 12936 2Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatricas Room Temperature Storage 12936 3Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 1Meatless Burgers Hot Dogs Not Always Full of Veggies 51049 2AlphaRx Reports Positive Preclinical Data on GAI 122 Against Liver Disease 51046 1AlphaRx Reports Positive Preclinical Data on GAI 122 Against Liver Disease 51046 2
...an counteract the effects of tumor-promoting molec...nvestigators at the University of Pennsylvania Sch...ers discovered that Srcasm acts like a brake in ep...h caused by a family of proteins called Src kinase...f Biological Chemistry, suggests a target for futu...
... producing special proteins that minimize environm...f intense environmental conditions in one of the w...that adult midges (Belgica antarctica) lose their ...at-shock proteins. Instead, like most animals, adu...e stressed. The discovery currently appears in the...
...young women to participate in the first U.S. study...prevent herpes and HIV infection. , If it is effec...stration, the gel would be an important weapon in ... to protect themselves from infection rather than ...e significance of the gel is that it potentially g...
Other Biology News:Signal protein shows promise for blocking tumor promoters in skin cells 2Unique gene regulation gives chilly bugs survival advantage at bottom of the world 2Unique gene regulation gives chilly bugs survival advantage at bottom of the world 3UCSF study will test new vaginal microbicide for herpes and HIV 2UCSF study will test new vaginal microbicide for herpes and HIV 3
G(5)ppp(5)G from Ambion
...gly essential for reducing sample and waste volume...ions. The eight-channel nano25 delivers with perfo... ,Features: , Real-time documented confirmation ... diagnostics detect and correct clogging, adapt to...
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
Microtiter Wells from Bethyl Laboratories
Biology Products: